penicillin v and Cardiovascular Diseases

penicillin v has been researched along with Cardiovascular Diseases in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (88.89)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexander, JJ; Mathew, J; Mosholder, AD; Nambiar, S; Smith, H1
Hviid, A; Pasternak, B; Svanström, H3
Steurer, J1
Jhund, PS; McMurray, JJ1
Brass, EP1
Mosholder, AD; Nambiar, S1
HOFFMANN, W1

Other Studies

9 other study(ies) available for penicillin v and Cardiovascular Diseases

ArticleYear
Cardiovascular risks with azithromycin and other antibacterial drugs.
    The New England journal of medicine, 2013, May-02, Volume: 368, Issue:18

    Topics: Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Death, Sudden, Cardiac; Female; Humans; Male; Penicillin V

2013
Use of azithromycin and death from cardiovascular causes.
    The New England journal of medicine, 2013, May-02, Volume: 368, Issue:18

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Cohort Studies; Denmark; Female; Humans; Infections; Male; Middle Aged; Penicillin V; Propensity Score; Registries; Risk; Young Adult

2013
[Not Available].
    Praxis, 2013, Aug-07, Volume: 102, Issue:16

    Topics: Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Female; Humans; Male; Penicillin V

2013
Cardiovascular risks with azithromycin.
    The New England journal of medicine, 2013, 08-08, Volume: 369, Issue:6

    Topics: Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Female; Humans; Male; Penicillin V

2013
Cardiovascular risks with azithromycin.
    The New England journal of medicine, 2013, 08-08, Volume: 369, Issue:6

    Topics: Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Death, Sudden, Cardiac; Female; Humans; Male; Penicillin V

2013
Cardiovascular risks with azithromycin.
    The New England journal of medicine, 2013, 08-08, Volume: 369, Issue:6

    Topics: Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Death, Sudden, Cardiac; Female; Humans; Male; Penicillin V

2013
Cardiovascular risks with azithromycin.
    The New England journal of medicine, 2013, 08-08, Volume: 369, Issue:6

    Topics: Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Death, Sudden, Cardiac; Female; Humans; Male; Penicillin V

2013
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study.
    BMJ (Clinical research ed.), 2014, Aug-19, Volume: 349

    Topics: Adult; Aged; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Cohort Studies; Cytochrome P-450 CYP3A Inhibitors; Denmark; Enzyme Inhibitors; Female; Humans; Logistic Models; Male; Middle Aged; Penicillin V; Propensity Score; Registries; Roxithromycin; Sex Factors

2014
[ON THE THERAPY OF TONSILLITIS IN GENERAL PRACTICE WITH SPECIAL REFERENCE TO TOXIC MYOCARDIAL AND CIRCULATORY DAMAGE].
    Die Medizinische Welt, 1963, Nov-16, Volume: 46

    Topics: Cardiovascular Diseases; Electrocardiography; General Practice; Penicillin V; Penicillins; Tonsillitis

1963